|Min SIP Amount||Not Supported|
|NAV||₹15.62 (10 Jun 2021)|
|Fund Started||22 Dec 2015|
|Fund Size||₹201 Cr|
|Aditya Birla Finance Ltd.||Financial||Debenture||11.7%|
|Hero FinCorp Ltd.||Financial||Debenture||9.4%|
|Housing Development Finance Corpn. Ltd.||Financial||Debenture||4.0%|
|HDFC Bank Ltd.||Financial||Equity||3.7%|
|ICICI Bank Ltd.||Financial||Equity||3.6%|
|Cadila Healthcare Ltd.||Healthcare||Equity||2.0%|
|Dr. Reddy's Laboratories Ltd.||Healthcare||Equity||1.2%|
UTI Dual Advantage Fixed Term Fund Series II IV (1997 Days) Regular Growth is a Hybrid Mutual Fund Scheme launched by UTI Mutual Fund. This scheme was made available to investors on 22 Dec 2015. null is the Current Fund Manager of UTI Dual Advantage Fixed Term Fund Series II IV (1997 Days) Regular Growth fund.The fund currently has an Asset Under Management(AUM) of ₹201 Cr and the Latest NAV as of 10 Jun 2021 is ₹15.62.
The UTI Dual Advantage Fixed Term Fund Series II IV (1997 Days) Regular Growth is rated Moderately High risk.
The scheme seeks to generate income and reduce interest rate volatility by investing in fixed income securities that are maturing on or before the date of maturity of the Scheme and generate capital appreciation by investing in equity and equity related instruments.